These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 21082864)

  • 1. Identification and synthesis of novel inhibitors of acetyl-CoA carboxylase with in vitro and in vivo efficacy on fat oxidation.
    Keil S; Müller M; Zoller G; Haschke G; Schroeter K; Glien M; Ruf S; Focken I; Herling AW; Schmoll D
    J Med Chem; 2010 Dec; 53(24):8679-87. PubMed ID: 21082864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of fat oxidation, but no sustained reduction of hepatic lipids by prolonged pharmacological inhibition of acetyl CoA carboxylase.
    Glien M; Haschke G; Schroeter K; Pfenninger A; Zoller G; Keil S; Müller M; Herling AW; Schmoll D
    Horm Metab Res; 2011 Aug; 43(9):601-6. PubMed ID: 21823054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationships of N-{3-[2-(4-alkoxyphenoxy)thiazol-5-yl]-1- methylprop-2-ynyl}carboxy derivatives as selective acetyl-CoA carboxylase 2 inhibitors.
    Gu YG; Weitzberg M; Clark RF; Xu X; Li Q; Zhang T; Hansen TM; Liu G; Xin Z; Wang X; Wang R; McNally T; Zinker BA; Frevert EU; Camp HS; Beutel BA; Sham HL
    J Med Chem; 2006 Jun; 49(13):3770-3. PubMed ID: 16789734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression analysis in rats treated with experimental acetyl-coenzyme A carboxylase inhibitors suggests interactions with the peroxisome proliferator-activated receptor alpha pathway.
    Waring JF; Yang Y; Healan-Greenberg CH; Adler AL; Dickinson R; McNally T; Wang X; Weitzberg M; Xu X; Lisowski A; Warder SE; Gu YG; Zinker BA; Blomme EA; Camp HS
    J Pharmacol Exp Ther; 2008 Feb; 324(2):507-16. PubMed ID: 18025247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent biphenyl- and 3-phenyl pyridine-based inhibitors of acetyl-CoA carboxylase.
    Haque TS; Liang N; Golla R; Seethala R; Ma Z; Ewing WR; Cooper CB; Pelleymounter MA; Poss MA; Cheng D
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5872-6. PubMed ID: 19740659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2.
    Abu-Elheiga L; Matzuk MM; Abo-Hashema KA; Wakil SJ
    Science; 2001 Mar; 291(5513):2613-6. PubMed ID: 11283375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of small molecule inhibitors of acetyl-CoA carboxylase 1 and 2 showing reduction of hepatic malonyl-CoA levels in vivo in obese Zucker rats.
    Bengtsson C; Blaho S; Saitton DB; Brickmann K; Broddefalk J; Davidsson O; Drmota T; Folmer R; Hallberg K; Hallén S; Hovland R; Isin E; Johannesson P; Kull B; Larsson LO; Löfgren L; Nilsson KE; Noeske T; Oakes N; Plowright AT; Schnecke V; Ståhlberg P; Sörme P; Wan H; Wellner E; Oster L
    Bioorg Med Chem; 2011 May; 19(10):3039-53. PubMed ID: 21515056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soraphen, an inhibitor of the acetyl-CoA carboxylase system, improves peripheral insulin sensitivity in mice fed a high-fat diet.
    Schreurs M; van Dijk TH; Gerding A; Havinga R; Reijngoud DJ; Kuipers F
    Diabetes Obes Metab; 2009 Oct; 11(10):987-91. PubMed ID: 19519866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals.
    Harwood HJ; Petras SF; Shelly LD; Zaccaro LM; Perry DA; Makowski MR; Hargrove DM; Martin KA; Tracey WR; Chapman JG; Magee WP; Dalvie DK; Soliman VF; Martin WH; Mularski CJ; Eisenbeis SA
    J Biol Chem; 2003 Sep; 278(39):37099-111. PubMed ID: 12842871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel bacterial acetyl coenzyme A carboxylase inhibitors with antibiotic efficacy in vivo.
    Freiberg C; Pohlmann J; Nell PG; Endermann R; Schuhmacher J; Newton B; Otteneder M; Lampe T; Häbich D; Ziegelbauer K
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2707-12. PubMed ID: 16870762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression, purification, and characterization of human acetyl-CoA carboxylase 2.
    Kim KW; Yamane H; Zondlo J; Busby J; Wang M
    Protein Expr Purif; 2007 May; 53(1):16-23. PubMed ID: 17223360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maximizing lipophilic efficiency: the use of Free-Wilson analysis in the design of inhibitors of acetyl-CoA carboxylase.
    Freeman-Cook KD; Amor P; Bader S; Buzon LM; Coffey SB; Corbett JW; Dirico KJ; Doran SD; Elliott RL; Esler W; Guzman-Perez A; Henegar KE; Houser JA; Jones CS; Limberakis C; Loomis K; McPherson K; Murdande S; Nelson KL; Phillion D; Pierce BS; Song W; Sugarman E; Tapley S; Tu M; Zhao Z
    J Med Chem; 2012 Jan; 55(2):935-42. PubMed ID: 22148323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetyl-CoA carboxylase inhibition for the treatment of metabolic syndrome.
    Harwood HJ
    Curr Opin Investig Drugs; 2004 Mar; 5(3):283-9. PubMed ID: 15083594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression, purification, and characterization of human and rat acetyl coenzyme A carboxylase (ACC) isozymes.
    Cheng D; Chu CH; Chen L; Feder JN; Mintier GA; Wu Y; Cook JW; Harpel MR; Locke GA; An Y; Tamura JK
    Protein Expr Purif; 2007 Jan; 51(1):11-21. PubMed ID: 16854592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel (4-piperidinyl)-piperazines as potent and orally active acetyl-CoA carboxylase 1/2 non-selective inhibitors: F-Boc and triF-Boc groups are acid-stable bioisosteres for the Boc group.
    Chonan T; Wakasugi D; Yamamoto D; Yashiro M; Oi T; Tanaka H; Ohoka-Sugita A; Io F; Koretsune H; Hiratate A
    Bioorg Med Chem; 2011 Mar; 19(5):1580-93. PubMed ID: 21324704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2.
    Savage DB; Choi CS; Samuel VT; Liu ZX; Zhang D; Wang A; Zhang XM; Cline GW; Yu XX; Geisler JG; Bhanot S; Monia BP; Shulman GI
    J Clin Invest; 2006 Mar; 116(3):817-24. PubMed ID: 16485039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of a monocyclic derivative as a selective ACC1 inhibitor by chemical modification of biphenyl ACC1/2 dual inhibitors.
    Mizojiri R; Tomita D; Sasaki M; Satoh Y; Yamamoto Y; Sumi H; Maezaki H
    Bioorg Med Chem; 2021 Apr; 35():116056. PubMed ID: 33607488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetyl-CoA carboxylases 1 and 2 show distinct expression patterns in rats and humans and alterations in obesity and diabetes.
    Kreuz S; Schoelch C; Thomas L; Rist W; Rippmann JF; Neubauer H
    Diabetes Metab Res Rev; 2009 Sep; 25(6):577-86. PubMed ID: 19618481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (4-Piperidinyl)-piperazine: a new platform for acetyl-CoA carboxylase inhibitors.
    Chonan T; Oi T; Yamamoto D; Yashiro M; Wakasugi D; Tanaka H; Ohoka-Sugita A; Io F; Koretsune H; Hiratate A
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6645-8. PubMed ID: 19853443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A herbal extract with acetyl-coenzyme A carboxylase inhibitory activity and its potential for treating metabolic syndrome.
    Chen CH; Chang MY; Lin YS; Lin DG; Chen SW; Chao PM
    Metabolism; 2009 Sep; 58(9):1297-305. PubMed ID: 19500808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.